PANES, Arnaud; FOURRIER-REGLAT, Annie; VERDOUX, Helene; DAUBECH-TOURNIER, Marie

doi:10.1016/j.lpm.2018.10.003

Métadonnées

Afficher la notice complète

Licence d’utilisation du document

PANES, Arnaud
Bordeaux population health [BPH]

FOURRIER-REGLAT, Annie

Bordeaux population health [BPH]

VERDOUX, Helene

Bordeaux population health [BPH]

Langue

Article de revue

Ce document a été publié dans

Presse medicale (Paris, France. 2018-10, vol. 47, n° 10, p. 886-891

Résumé en anglais

The psychiatric patients are not only particularly exposed to benzodiazepines; they may also be more vulnerable to their side effects than general population. Benzodiazepines are frequently misused in psychiatric patients in terms of duration, dose and number of concomitant medications. There is no evidence that benzodiazepines are effective against most psychiatric disorders, including depression and suicidal risk. Several studies have shown associations between benzodiazepine use and depression worsening, increased disinhibition, suicide risk, anxiety, aggression, and even mortality in patients with psychiatric disorders. Despite the common use of benzodiazepine drugs by clinicians, large and methodologically sound studies are lacking to document the patterns of benzodiazepine use in populations with psychiatric disorders and their specific risks in these patients. It is not known whether it is legitimate to apply the good practice recommendations for benzodiazepines in patients with severe psychiatric disorders.< Réduire

Mots clés en anglais

PharmacoEpi-Drugs

Métadonnées

Partager cette publication !

Licence d’utilisation du document

Usages et mesusages des benzodiazepines chez les patients souffrant de troubles psychiatriques

Langue

Ce document a été publié dans

Résumé en anglais

Mots clés en anglais

URI

DOI

Unités de recherche